Clinical Trial Update: Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stiripentol (Diacomit) as monotherapy for primary hyperoxaluria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Drugs mentioned

• Stiripentol (stiripentol)

Snippet

Sponsor: Biocodex | Conditions: Primary Hyperoxaluria | Phase 2 | Status: COMPLETED